SANUWAVE Health, Inc. Common Stock

Day range

$5.10 – $5.38

Open

$5.13

Prev close

$5.22

Volume

35.5K

Market cap

$44.9M

Shares out

8.6M

P/E

3.14

P/S

1.02

P/B

16.11

P/FCF

10.58

ROE

513.6%

ROA

39.1%

Debt/Equity

6.89

Div yield

0.00%

As of Oct 23, 2026

• Preliminary resultsJul 13, 2026

  On July 13, 2026, Sanuwave Health, Inc., a Nevada corporation (the "Company"), issued a press release announcing certain preliminary financial results for the quarter ended June 30, 2026.

• Guidance issuance or updateJun 16, 2026

  On June 16, 2026, Sanuwave Health, Inc., a Nevada corporation (the "Company"), issued a press release announcing updated guidance for the quarter ended June 30, 2026.

• Annual meeting resultsJun 15, 2026

  On June 11, 2026, Sanuwave Health, Inc. (the "Company") held its 2026 annual meeting of stockholders. The following matters (the "Proposals") were voted upon by the stockholders with the final voting results as shown: Proposal 1. To elect five directors, Morgan Frank, Gregory Bazar, Jeffrey Blizard, Ian Miller and James Tyler, to serve until the 2027 annual meeting of stockholders.

• Preliminary resultsApr 16, 2026

  On April 16, 2026, Sanuwave Health, Inc., a Nevada corporation (the "Company"), issued a press release announcing certain preliminary financial results for the quarter ended March 31, 2026.

• Financial restatementMar 13, 2026

  the audit committee of the board of directors of the Company...concluded that the following should no longer be relied upon: (a) the Company's previously issued unaudited condensed consolidated financial statements as of and for (i) the three and nine months ended September 30, 2024, (ii) the three and six months ended June 30, 2024, (iii) the three months ended March 31, 2024, (iv) the three and nine months ended September 30, 2025, (v) the three and six months ended June 30, 2025, and (vi) the three months ended March 31, 2025 and (b) the Company's previously issued audited consolidated financial statements as of and for the year ended December 31, 2024.

Days to cover

3.9

Short interest

245.5K

Avg volume

62.82K

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Sanuwave Announces Q2 FY2026 Financial Results
  negativeGlobeNewswire Inc.· Aug 6, 2026
• Sanuwave Announces Revenues and Financial Results for Q1 FY2026
  neutralGlobeNewswire Inc.· May 12, 2026
• Sanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial Results
  positiveGlobeNewswire Inc.· May 6, 2026
• Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-Year
  neutralGlobeNewswire Inc.· Apr 16, 2026
• Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025
  positiveGlobeNewswire Inc.· Mar 26, 2026